Trixeo Aerosphere - Formoterol fumarate with glycopyrronium and budesonide
AstraZeneca
Description
Long acting muscarinic antagonist, long-acting beta 2 agonist and inhaled corticosteroid.
Two inhalations twice daily
Indications
For the maintenance treatment of moderate to severe COPD.
Contraindications
Use only if potential benefit outweighs risk in the case of hepatic failure, pregnancy and when breast feeding.
Preparations Available
Pressurised inhalation
Sizes Available
Pressurised inhalation
Trixeo Aerosphere 5 mcg/7.2 mcg/160 mcg, 120 doses
More on: Bronchodilators , Compound preparations , Long-acting selective beta2: agonists